📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review. (2022)

First Author: Moss S

Attributed to: Adjunctive Ivermectin Mass Drug Administration for Malaria Elimination: A cluster randomized trial funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12936-022-04181-y

PubMed Identifier: 35690758

Publication URI: http://europepmc.org/abstract/MED/35690758

Type: Journal Article/Review

Volume: 21

Parent Publication: Malaria journal

Issue: 1

ISSN: 1475-2875